MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma

to related objects

Location
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2041-1723
Extent
Online-Ressource
Language
Englisch
Notes
online resource.

Bibliographic citation
MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma ; volume:13 ; number:1 ; day:28 ; month:6 ; year:2022 ; pages:1-17 ; date:12.2022
Nature Communications ; 13, Heft 1 (28.6.2022), 1-17, 12.2022

Creator
Tao, Ling
Mohammad, Mahmoud A.
Milazzo, Giorgio
Moreno-Smith, Myrthala
Patel, Tajhal D.
Zorman, Barry
Badachhape, Andrew
Hernandez, Blanca E.
Wolf, Amber B.
Zeng, Zihua
Foster, Jennifer H.
Aloisi, Sara
Sumazin, Pavel
Zu, Youli
Hicks, John
Ghaghada, Ketan B.
Putluri, Nagireddy
Perini, Giovanni
Coarfa, Cristian
Barbieri, Eveline
Contributor
SpringerLink (Online service)

DOI
10.1038/s41467-022-31331-2
URN
urn:nbn:de:101:1-2022082010013027370978
Rights
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Last update
15.08.2025, 7:35 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Show original at data provider

Associated

  • Tao, Ling
  • Mohammad, Mahmoud A.
  • Milazzo, Giorgio
  • Moreno-Smith, Myrthala
  • Patel, Tajhal D.
  • Zorman, Barry
  • Badachhape, Andrew
  • Hernandez, Blanca E.
  • Wolf, Amber B.
  • Zeng, Zihua
  • Foster, Jennifer H.
  • Aloisi, Sara
  • Sumazin, Pavel
  • Zu, Youli
  • Hicks, John
  • Ghaghada, Ketan B.
  • Putluri, Nagireddy
  • Perini, Giovanni
  • Coarfa, Cristian
  • Barbieri, Eveline
  • SpringerLink (Online service)

Other Objects (12)

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

LRP8‐mediated selenocysteine uptake is a targetable vulnerability in MYCN‐amplified neuroblastoma

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

SMAD9-MYCN positive feedback loop represents a unique dependency for MYCN-amplified neuroblastoma

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

Hochschulschrift

MYCN, proliferative heterogeneity and treatment response in neuroblastoma

MYCN modulates the restriction point and ferroptosis in Neuroblastoma

Hochschulschrift

MYCN modulates the restriction point and ferroptosis in Neuroblastoma

MYCN modulates the restriction point and ferroptosis in Neuroblastoma

Hochschulschrift

MYCN modulates the restriction point and ferroptosis in Neuroblastoma

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Genomic profile of MYCN non-amplified neuroblastoma and potential for immunotherapeutic strategies in neuroblastoma

Decoding the metabolic program of deregulated MYCN expression in neuroblastoma

Decoding the metabolic program of deregulated MYCN expression in neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

MTHFD1 regulates the NADPH redox homeostasis in MYCN-amplified neuroblastoma

MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling

MYCN amplification in neuroblastoma: sequence, chromatin landscape, and genome remodeling

MYCN protein stability is a better prognostic indicator in neuroblastoma

MYCN protein stability is a better prognostic indicator in neuroblastoma

Related objects